Reasons for Seeking Genetic Susceptibility Testing Among First-Degree Relatives of People With Alzheimer Disease
- 1 April 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 17 (2) , 86-93
- https://doi.org/10.1097/00002093-200304000-00006
Abstract
Advances in genetic research have provided a basis for susceptibility testing for Alzheimer disease (AD). Prior surveys have examined attitudes toward genetic testing for AD in hypothetical scenarios, but it is unclear what reasons would motivate people to seek testing in real-life situations. This study presents data from the first randomized trial to evaluate genetic susceptibility testing for asymptomatic adult children of people with AD. We examined (1) reasons endorsed as motivations for seeking testing, (2) demographic characteristics associated with these reasons, and (3) how these reasons related to the eventual decision to pursue testing. Eligible participants were 206 adult children of people with AD (mean age 53 years; 72% female; 93% white), 77.7% of whom (n = 160) went on to seek testing. Participants endorsed numerous reasons for seeking susceptibility testing (mean 7.2), encompassing a range of motivations. The most commonly endorsed reasons were as follows: (1) to contribute to research (93.9%), (2) to arrange personal affairs (87.4%), and (3) the hope that effective treatment will be developed (86.8%). Women strongly endorsed more reasons for seeking testing than men (pThis publication has 25 references indexed in Scilit:
- A Worldwide Assessment of the Frequency of Suicide, Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for Huntington DiseaseAmerican Journal of Human Genetics, 1999
- Suicide in Two Patients with a Diagnosis of Probable Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1999
- The Psychological Impact of Genetic Testing for Alzheimer DiseaseGenetic Testing, 1999
- The Genetics of Alzheimer DiseaseArchives of Neurology, 1998
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- The P1 Component of the Middle Latency Auditory Potential May Differentiate a Brainstem Subgroup of Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1997
- Anticipatory Dementia: A Link Between Memory Appraisals and Concerns About Developing Alzheimer's DiseaseThe Gerontologist, 1996
- Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer diseasePublished by American Medical Association (AMA) ,1995
- Consensus Statement on Predictive Testing for Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1995
- Attitudes toward clinical trials among patients and the publicJAMA, 1982